Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment

FASEB Journal

Volumn 26, Issue 11, 2012, Pages 4696-4709

  Mo, Michelle ^a   Erdelyi, Ildiko ^b   Szigeti Buck, Klara ^b   Benbow, Jennifer H ^a   Ehrlich, Barbara E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Comparative Medicine ^*  (United States)

Author keywords

1,4,5 Trisphosphate receptor; Ibudilast; Inositol; Intracellular calcium signaling; Neuronal calcium sensor 1

Indexed keywords

2 (2,4 DICHLOROPHENYL) 3 (1 METHYL 3 INDOLYL)MALEIMIDE; CALCIUM; IBUDILAST; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; LITHIUM CARBONATE; NEURONAL CALCIUM SENSOR; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CONTROLLED STUDY; DRUG TOLERABILITY; FEMALE; HEART DISEASE; HUMAN; MOUSE; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROPHYLAXIS; SENSORIMOTOR FUNCTION; SURVIVAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALCIUM SIGNALING; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; GLYCOGEN SYNTHASE KINASE 3; LITHIUM; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASMS, EXPERIMENTAL; NEUROPROTECTIVE AGENTS; PACLITAXEL; PERIPHERAL NERVOUS SYSTEM DISEASES; PHOSPHODIESTERASE INHIBITORS; PYRIDINES;

MUS;

EID: 84868284804     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-214643     Document Type: Article

References (50)

1. Pachman, D. R., Barton, D. L., Watson, J. C., and Loprinzi, C. L. (2011) Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin. Pharmacol. Ther. 90, 377-387
2. Lema, M. J., Foley, K. M., and Hausheer, F. H. (2010) Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain. Oncologist 15(Suppl. 2), 3-8
3. Windebank, A. J., and Grisold, W. (2008) Chemotherapy-induced neuropathy. J. Periph. Nerv. Syst. 13, 27-46
4. Wani, M. C., Taylor, H. L., Wall, M. E., Coggon, P., and McPhail, A. T. (1971) Plant antitumor agents. VI. The isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia. J. Am. Chem. Soc. 93, 2325-2327
5. Chang, A. Y., and Garrow, G. C. (1995) Pilot study of vinorelbine (Navelbine) and paclitaxel (Taxol) in patients with refractory breast cancer and lung cancer. Sem. Oncol. 22, 66-70; discussion 70-61
6. Baird, R. D., Tan, D. S., and Kaye, S. B. (2010) Weekly paclitaxel in the treatment of recurrent ovarian cancer. Nat. Rev. Clin. Oncol. 7, 575-582
7. Sarosy, G. A., Hussain, M. M., Seiden, M. V., Fuller, A. F., Nikrui, N., Goodman, A., Minasian, L., Reed, E., Steinberg, S. M., and Kohn, E. C. (2010) Ten-year follow-up of a phase 2 study of dose-intense paclitaxel with cisplatin and cyclophosphamide as initial therapy for poor-prognosis, advanced-stage epithelial ovarian cancer. Cancer. 116, 1476-1484
8. Rowinsky, E. K., Chaudhry, V., Cornblath, D. R., and Donehower, R. C. (1993) Neurotoxicity of Taxol. J. Natl. Cancer Inst. Monogr. 15, 107-115
9. Weiss, J. L., Hui, H., and Burgoyne, R. D. (2010) Neuronal calcium sensor-1 regulation of calcium channels, secretion, and neuronal outgrowth. Cell. Mol. Neurobiol. 30, 1283-1292
10. Boehmerle, W., Splittgerber, U., Lazarus, M. B., McKenzie, K. M., Johnston, D. G., Austin, D. J., and Ehrlich, B. E. (2006) Paclitaxel induces calcium oscillations via an inositol 1,4,5-trisphosphate receptor and neuronal calcium sensor 1-dependent mechanism. Proc. Natl. Acad. Sci. U. S. A. 103, 18356-18361
11. Wang, M. S., Davis, A. A., Culver, D. G., Wang, Q., Powers, J. C., and Glass, J. D. (2004) Calpain inhibition protects against Taxol-induced sensory neuropathy. Brain 127, 671-679
12. Boehmerle, W., Zhang, K., Sivula, M., Heidrich, F. M., Lee, Y., Jordt, S. E., and Ehrlich, B. E. (2007) Chronic exposure to paclitaxel diminishes phosphoinositide signaling by calpainmediated neuronal calcium sensor-1 degradation. Proc. Natl. Acad. Sci. U. S. A. 104, 11103-11108
13. Fernyhough, P., and Calcutt, N. A. (2010) Abnormal calcium homeostasis in peripheral neuropathies. Cell Calcium 47, 130-139
14. Siau, C., and Bennett, G. J. (2006) Dysregulation of cellular calcium homeostasis in chemotherapy-evoked painful peripheral neuropathy. Anesth. Analg. 102, 1485-1490
15. Schlecker, C., Boehmerle, W., Jeromin, A., DeGray, B., Varshney, A., Sharma, Y., Szigeti-Buck, K., and Ehrlich, B. E. (2006) Neuronal calcium sensor-1 enhancement of InsP3 receptor activity is inhibited by therapeutic levels of lithium. J. Clin. Invest. 116, 1668-1674
16. Benbow, J. H., Mann, T., DeGray, B., and Ehrlich, B. E. (2012) Protection against paclitaxel induced decreases in calcium signaling. 286, 34575-34582
17. Saha, L., Hota, D., and Chakrabarti, A. (2012) Evaluation of Lercanidipine in paclitaxel-induced neuropathic pain model in rat: a preliminary study. Pain Res. Treat. 2012, 5
18. Rahn, E. J., Zvonok, A. M., Thakur, G. A., Khanolkar, A. D., Makriyannis, A., and Hohmann, A. G. (2008) Selective activation of cannabinoid CB2 receptors suppresses neuropathic nociception induced by treatment with the chemotherapeutic agent paclitaxel in rats. J. Pharmacol. Exp. Ther. 327, 584-591
19. Wood, A. J., Goodwin, G. M., De Souza, R., and Green, A. R. (1986) The pharmacokinetic profile of lithium in rat and mouse; an important factor in psychopharmacological investigation of the drug. Neuropharmacology 25, 1285-1288
20. Pourmohammadi, N., Alimoradi, H., Mehr, S. E., Hassanzadeh, G., Hadian, M. R., Sharifzadeh, M., Bakhtiarian, A., and Dehpour, A. R. (2012) Lithium attenuates peripheral neuropathy induced by Paclitaxel in rats. Basic Clin. Pharmacol. Toxicol. 110, 231-237
21. Ledeboer, A., Liu, T., Shumilla, J. A., Mahoney, J. H., Vijay, S., Gross, M. I., Vargas, J. A., Sultzbaugh, L., Claypool, M. D., Sanftner, L. M., Watkins, L. R., and Johnson, K. W. (2006) The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biol. 2, 279-291
22. Shakoori, A., Mai, W., Miyashita, K., Yasumoto, K., Takahashi, Y., Ooi, A., Kawakami, K., and Minamoto, T. (2007) Inhibition of GSK-3 beta activity attenuates proliferation of human colon cancer cells in rodents. Cancer Sci. 98, 1388-1393
23. Sharma, A., and Straubinger, R. M. (1994) Novel taxol formulations: preparation and characterization of taxol-containing liposomes. Pharm. Res. 11, 889-896
24. Shree, T., Olson, O. C., Elie, B. T., Kester, J. C., Garfall, A. L., Simpson, K., Bell-McGuinn, K. M., Zabor, E. C., Brogi, E., and Joyce, J. A. (2011) Macrophages and cathepsin proteases blunt chemotherapeutic response in breast cancer. Genes Dev. 25, 2465-2479
25. Johenning, F. W., Zochowski, M., Conway, S. J., Holmes, A. B., Koulen, P., and Ehrlich, B. E. (2002) Distinct intracellular calcium transients in neurites and somata integrate neuronal signals. J. Neurosci. 22, 5344-5353
26. Costa, R., Motta, E. M., Dutra, R. C., Manjavachi, M. N., Bento, A. F., Malinsky, F. R., Pesquero, J. B., and Calixto, J. B. (2011) Anti-nociceptive effect of kinin B and B receptor antagonists on peripheral neuropathy induced by paclitaxel in mice. Brit. J. Pharmacol. 164, 681-693
27. Makoukji, J., Belle, M., Meffre, D., Stassart, R., Grenier, J., Shackleford, G., Fledrich, R., Fonte, C., Branchu, J., Goulard, M., de Waele, C., Charbonnier, F., Sereda, M. W., Baulieu, E. E., Schumacher, M., Bernard, S., and Massaad, C. (2012) Lithium enhances remyelination of peripheral nerves. Proc. Natl. Acad. Sci. U. S. A. 109, 3973-3978
28. Benbow, J. H., DeGray, B., and Ehrlich, B. E. (2011) Protection of neuronal calcium sensor 1 protein in cells treated with paclitaxel. J. Biol. Chem. 286, 34575-34582
29. O'Brien, W. T., and Klein, P. S. (2009) Validating GSK3 as an in vivo target of lithium action. Biochem. Soc. Trans. 37, 1133-1138
30. Wada, A. (2009) GSK-3 inhibitors and insulin receptor signaling in health, disease, and therapeutics. Front. Biosci. 14, 1558-1570
31. Fishman, P., Bar-Yehuda, S., Ohana, G., Barer, F., Ochaion, A., Erlanger, A., and Madi, L. (2004) An agonist to the A3 adenosine receptor inhibits colon carcinoma growth in mice via modulation of GSK-3 beta and NF-B. Oncogene 23, 2465-2471
32. Naderi, S., Gutzkow, K. B., Lahne, H. U., Lefdal, S., Ryves, W. J., Harwood, A. J., and Blomhoff, H. K. (2004) cAMP-induced degradation of cyclin D3 through association with GSK-3+. J. Cell Sci. 117, 3769-3783
33. Lee, M., and Hopkins, L. E. (1980) Attenuation of chemotherapy-induced neutropenia with lithium carbonate. Am. J. Hosp. Pharm. 37, 1066-1071
34. Lyman, G. H., Williams, C. C., and Preston, D. (1980) The use of lithium carbonate to reduce infection and leukopenia during systemic chemotherapy. N. Engl. J. Med. 302, 257-260
35. Lyman, G. H., Williams, C. C., Preston, D., Goldman, A., Dinwoodie, W. R., Saba, H., Hartmann, R., Jensen, R., and Shukovsky, L. (1981) Lithium carbonate in patients with small cell lung cancer receiving combination chemotherapy. Am. J. Med. 70, 1222-1229
36. Yeh, E. T., and Bickford, C. L. (2009) Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management. J. Am. Coll. Cardiol. 53, 2231-2247
37. Zhang, K., Heidrich, F. M., DeGray, B., Boehmerle, W., and Ehrlich, B. E. (2010) Paclitaxel accelerates spontaneous calcium oscillations in cardiomyocytes by interacting with NCS-1 and the InsP3R. J. Mol. Cell. Cardiol. 49, 829-835
38. Steinherz, L. J., Steinherz, P. G., and Tan, C. (1995) Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients. Med. Ped. Oncol. 24, 352-361
39. Hama, A. T., Broadhead, A., Lorrain, D. S., and Sagen, J. (2012) The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain. J. Neurotrauma 29, 600-610
40. Colombo, N., Bini, S., Miceli, D., Bogliun, G., Marzorati, L., Cavaletti, G., Parmigiani, F., Venturino, P., Tedeschi, M., Frattola, L., Buratti, C., and Mangioni, C. (1995) Weekly cisplatin-glutathione in relapsed ovarian carcinoma. Intl. J. Gynecol. Cancer 5, 81-86
41. Smyth, J. F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R. J., Quinn, K. J., and Tedeschi, M. (1997) Glutathione reduces the toxicity and improves quality of life of women diagnosed with ovarian cancer treated with cisplatin: results of a doubleblind, randomised trial. Ann. Oncol. 8, 569-573
42. Lersch, C., Schmelz, R., Eckel, F., Erdmann, J., Mayr, M., Schulte-Frohlinde, E., Quasthoff, S., Grosskreutz, J., and Adelsberger, H. (2002) Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer. Clin. Colorectal Cancer 2, 54-58
43. Amara, S. (2008) Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy. Ann. Pharmacother. 42, 1481-1485
44. Wang, W. S., Lin, J. K., Lin, T. C., Chen, W. S., Jiang, J. K., Wang, H. S., Chiou, T. J., Liu, J. H., Yen, C. C., and Chen, P. M. (2007) Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist 12, 312-319
45. Grothey, A., Nikcevich, D. A., Sloan, J. A., Kugler, J. W., Silberstein, P. T., Dentchev, T., Wender, D. B., Novotny, P. J., Chitaley, U., Alberts, S. R., and Loprinzi, C. L. (2011) Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J. Clin. Oncol. 29, 421-427
46. Rousset, M., Cens, T., Gavarini, S., Jeromin, A., and Charnet, P. (2003) Down-regulation of voltage-gated Ca2 channels by neuronal calcium sensor-1 is beta subunit-specific. J. Biol. Chem. 278, 7019-7026
47. Wang, J. T., Medress, Z. A., and Barres, B. A. (2012) Axon degeneration: molecular mechanisms of a self-destruction pathway. J. Cell. Biol. 196, 7-18
48. Phiel, C. J., and Klein, P. S. (2001) Molecular targets of lithium action. Annu. Rev. Pharmacol. Toxicol. 41, 789-813
49. Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., and Belmaker, R. H. (2009) Knockout mice in understanding the mechanism of action of lithium. Biochem. Soc. Trans. 37, 1121-1125
50. Johenning, F. W., Wenk, M. R., Uhlen, P., Degray, B., Lee, E., De Camilli, P., and Ehrlich, B. E. (2004) InsP3-mediated intracellular calcium signalling is altered by expression of synaptojanin-1. Biochem. J. 382, 687-694